DC‐CIK cells derived from ovarian cancer patient menstrual blood activate the TNFR1‐ASK1‐AIP1 pathway to kill autologous ovarian cancer stem cells. The gene discussed is TNFRSF1A; the disease is ovarian carcinoma.